Publicaciones en las que colabora con Matías Antonio Llabrés Martínez (27)

2019

  1. New injectable two-step forming hydrogel for delivery of bioactive substances in tissue regeneration

    Regenerative Biomaterials, Vol. 6, Núm. 3, pp. 149-162

2017

  1. Development of a standard method for in vitro evaluation of Triamcinolone and BMP-2 diffusion mechanism from thermosensitive and biocompatible composite hyaluronic acid-pluronic hydrogels

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 284-291

  2. Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2

    Journal of Pharmaceutical Sciences, Vol. 106, Núm. 11, pp. 3353-3362

2005

  1. Justificación teórica del modelo lineal de Wagner para predecir la dosis de fármacos con cinética de eliminación de Michaelis-Menten

    Ciencia y Tecnologia Pharmaceutica, Vol. 15, Núm. 4, pp. 177-182

2004

  1. Farmacocinética de población del valproato: Influencia de la dosis y la comedicación

    Ciencia y Tecnologia Pharmaceutica, Vol. 14, Núm. 3, pp. 110-116

  2. Methadone implants for methadone maintenance treatment. In vitro and in vivo animal studies

    Journal of Controlled Release, Vol. 95, Núm. 3, pp. 413-421

  3. Optimización del tratamiento con Carbamazepina: Efecto de la dosis, de la variabilidad interindividual y de la coadministración de otros fármacos

    Ciencia y Tecnologia Pharmaceutica, Vol. 14, Núm. 1, pp. 13-17

2001

  1. In vivo-in vitro study of biodegradable methadone delivery systems

    Biomaterials, Vol. 22, Núm. 6, pp. 563-570

1999

  1. Biodistribution and liver histological studies of biodegradable nanospheres

    Proceedings of the Controlled Release Society

  2. In vitro-in vivo study of dl-PLA microspheres containing methadone

    Proceedings of the Controlled Release Society

  3. One-month sustained release microspheres of 125I-bovine calcitonin In vitro - In vivo studies

    Journal of Controlled Release, Vol. 59, Núm. 1, pp. 55-62

1998

  1. Effect of storage on the stability of DL-PLA microspheres containing methadone

    International Journal of Pharmaceutics, Vol. 166, Núm. 2, pp. 223-225

  2. In situ rat-liver perfusion for the study of biodegradable nanospheres uptake.

    Proceedings of the Controlled Release Society

1997

  1. Effect of surfactant agents on the release of 125I-bovine calcitonin from PLGA microspheres: In vitro - in vivo study

    Journal of Controlled Release, Vol. 43, Núm. 1, pp. 59-64

1996

  1. Degradation of DL-PLA-methadone microspheres during in vitro release

    International Journal of Pharmaceutics, Vol. 140, Núm. 2, pp. 219-227

  2. Optimization of 7-day release (in vitro) from DL-PLA methadone microspheres

    International Journal of Pharmaceutics, Vol. 134, Núm. 1-2, pp. 203-211

  3. Preparation and evaluation of insulin-loaded poly(DL-lactide) microspheres using an experimental design

    International Journal of Pharmaceutics, Vol. 142, Núm. 2, pp. 135-142

1995

  1. Biodisponibilidad de los fármacos administrados por yeyunostomía mínima a catéter. Estudio clínico-experimental.

    Nutricion Hospitalaria, Vol. 10, Núm. 3, pp. 181-184

  2. Release control of albumin from polylactic acid microspheres

    International Journal of Pharmaceutics, Vol. 125, Núm. 2, pp. 223-230

1993

  1. In vitro release optimization of three days methadone microspheres

    Proceedings of the Controlled Release Society